About this Immunology and Microbiology article
Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma by Albertini, Mark R.; Yang, Richard K.; Ranheim, Erik A.; Hank, Jacquelyn A.; Zuleger, Cindy L.; Weber, Sharon; Neuman, Heather; Hartig, Greg; Weigel, Tracey; Mahvi, David; Henry, Mary Beth; Quale, Renae; McFarland, Thomas; Gan, Jacek; Carmichael, Lakeesha; Kim, KyungMann; Loibner, Hans; Gillies, Stephen D.; Sondel, Paul M. is a Immunology and Microbiology article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Immunology and Microbiology.
- Author
- Albertini, Mark R.; Yang, Richard K.; Ranheim, Erik A.; Hank, Jacquelyn A.; Zuleger, Cindy L.; Weber, Sharon; Neuman, Heather; Hartig, Greg; Weigel, Tracey; Mahvi, David; Henry, Mary Beth; Quale, Renae; McFarland, Thomas; Gan, Jacek; Carmichael, Lakeesha; Kim, KyungMann; Loibner, Hans; Gillies, Stephen D.; Sondel, Paul M.
- Publisher
- Springer-Verlag; Springer Verlag; Springer Science and Business Media LLC (ISSN 0340-7004)
- Published
- 2018
- Language
- EN
- Field
- Immunology and Microbiology (Life Sciences)